Trinity Biotech (TRIB) Cash from Operations (2016 - 2024)
Historic Cash from Operations for Trinity Biotech (TRIB) over the last 16 years, with Q4 2024 value amounting to $3.6 million.
- Trinity Biotech's Cash from Operations rose 105580.65% to $3.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$26000.0, marking a year-over-year increase of 9942.71%. This contributed to the annual value of -$4.2 million for FY2024, which is 6373.63% up from last year.
- As of Q4 2024, Trinity Biotech's Cash from Operations stood at $3.6 million, which was up 105580.65% from -$3.9 million recorded in Q2 2024.
- Trinity Biotech's Cash from Operations' 5-year high stood at $14.8 million during Q4 2020, with a 5-year trough of -$7.1 million in Q2 2023.
- Moreover, its 5-year median value for Cash from Operations was $1.2 million (2020), whereas its average is $2.0 million.
- Per our database at Business Quant, Trinity Biotech's Cash from Operations crashed by 12209.4% in 2022 and then soared by 105580.65% in 2024.
- Quarter analysis of 5 years shows Trinity Biotech's Cash from Operations stood at $14.8 million in 2020, then tumbled by 73.66% to $3.9 million in 2021, then plummeted by 41.51% to $2.3 million in 2022, then tumbled by 86.45% to $310000.0 in 2023, then soared by 1055.81% to $3.6 million in 2024.
- Its Cash from Operations was $3.6 million in Q4 2024, compared to -$3.9 million in Q2 2024 and -$3317.0 in Q1 2024.